Sign in to continue:
Type a stock name or symbol, then select from the suggestions.
Hongkong Land (HKL) has made a landmark commitment to China, unveiling West Bund Central in Shanghai — the group’s largest single investment to date, valued at US$11.5 billion. While HKL has traditionally been associated...
Lim Seong Hai Capital Berhad (LSH Capital) IPO Purpose of IPO: LSH Capital aims to raise RM168.08 million through its IPO to fund business expansion, repay bank borrowings, and for working capital. The...
Visen Pharmaceuticals, a biopharmaceutical company specializing in endocrinology treatments in China, is set to list on the Hong Kong Stock Exchange under the ticker 02561.HK. The IPO is scheduled for March 21, 2025, aiming...
